Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 8


Results: 9
    1
    2
    3

    Study protocol of KeyPemls-004: A phase 2 study of pembrolizumab in combination with plinabulin and docetaxel in previously treated patients with metastatic non-small cell lung cancer and progressive disease (PD) after immunotherapy (PD-1/PD-L1 inhibitor) alone or in combination with platinum-doublet chemotherapy

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 8, p. 773, doi. 10.1111/1759-7714.14806
    By:
    • Jia Liu;
    • Minjiang Chen;
    • Xiaoxing Gao;
    • Xiaoyan Liu;
    • Jing Zhao;
    • Ruili Pan;
    • Wei Zhong;
    • Yan Xu;
    • Mengzhao Wang
    Publication type:
    Article
    4
    5
    6
    7
    8
    9